Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.

Farchadi, David; Slatkin, Neal E; Stambler, Nancy; Israel, Robert J; Matus, Michael

Farchadi, David; Slatkin, Neal E; Stambler, Nancy; Israel, Robert J; Matus, Michael.

Afiliação

Farchadi D; Loma Linda University Medical Center, Loma Linda, California.
Slatkin NE; School of Medicine, University of California Riverside, Riverside, California.
Stambler N; Salix Pharmaceuticals, Bridgewater, New Jersey.
Israel RJ; Progenics Pharmaceuticals, Inc, a subsidiary of Lantheus Holdings, Inc, Clinical Research, New York, New York.
Matus M; Bausch Health US, LLC, Bridgewater, New Jersey.

Curr Ther Res Clin Exp ; 98: 100694, 2023.

Article em En | MEDLINE | ID: mdl-36875317

Palavras-chave

Analgesia; Cancer pain; Constipation; Laxatives; Methylnaltrexone; Opioid therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Curr Ther Res Clin Exp Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google